Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $315
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Equal-Weight rating on HCA Healthcare (NYSE:HCA) and increased the price target from $303 to $315.
March 28, 2024 | 2:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on HCA Healthcare and raised the price target from $303 to $315.
The increase in the price target by Wells Fargo suggests a positive outlook on HCA Healthcare's stock, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100